IBDEI2LQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=EXC-BEN LESION-FACE,MUCOUS^7^20
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^11^20
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=EXC-MAL LESION-FACE,MUCOUS^10^20
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^31^20
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=SHAVING-EPIDERM-FACE,MUCOUS^30^20
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^28^20
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^26^20
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^25^20
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=WOUND HEALING^39^20
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=SKIN TEST^33^20
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=MICROBIOLOGY^15^20
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=MOHS CHEMOSURGERY^17^20
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=INJECTIONS^14^20
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=PEEL^19^20
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=PHOTOTHERAPY^20^20
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=REPAIR-COMPLEX-FACE^23^20
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=REPAIR-COMPLEX-NK/HAND/FT^24^20
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=REPAIR-COMPLEX-TRUNK^21^20
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=TISSUE REARRANGMNT-FACE/NECK/HAND/FOOT^36^20
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=TISSUE REARRANGMNT-SCALP/ARMS/LEGS^35^20
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=TISSUE REARRANGMNT-TRUNK^34^20
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=REPAIR-COMPLEX-SCALP^22^20
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=TISSUE REARRANGMNT-EYELID/NOSE/EAR/LIP^37^20
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=BIOPSY^1^20
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=TISSUE REARRANGEMENT-ANY AREA^38^20
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=A DIAGNOSES^1^21
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=D DIAGNOSES^4^21
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=E DIAGNOSES^5^21
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=F DIAGNOSES^6^21
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=I DIAGNOSES^9^21
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=K DIAGNOSES^10^21
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=M DIAGNOSES^12^21
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=N DIAGNOSES^13^21
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=P DIAGNOSES^15^21
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=R DIAGNOSES^16^21
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=S DIAGNOSES^17^21
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=T DIAGNOSES^18^21
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=V DIAGNOSES^20^21
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=X DIAGNOSES^22^21
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=C DIAGNOSES^3^21
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=W DIAGNOSES^21^21
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=B DIAGNOSES^2^21
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=G DIAGNOSES^7^21
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=H DIAGNOSES^8^21
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=L DIAGNOSES^11^21
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=O DIAGNOSES^14^21
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=U DIAGNOSES^19^21
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=Z DIAGNOSES^23^21
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=NEW PATIENT^3^22
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=ESTABLISHED PATIENT^1^22
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=CONSULTATIONS^2^22
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=PREVENTIVE MEDICINE-EST PT^4^22
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^5^22
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=RISK FACTOR REDUCTION-GRP^6^22
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=RISK FACTOR REDUCTION-IND^7^22
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=OTHER^3^23
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=EDUCATION/TRAINING^1^23
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=MEDICAL NUTRITION THERAPY^2^23
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=WOUND TREATMENT^8^23
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=DIABETES^1^24
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=NEW PATIENT^3^25
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=ESTABLISHED PATIENT^2^25
